1.7. Analysis.
Comparison 1 Oropharyngeal colostrum (OPC) versus control (water, saline, or no intervention), Outcome 7 Reported adverse effects.
Reported adverse effects | |||
---|---|---|---|
Study | Outcome | Definition | Comments |
Glass 2017 | No adverse effects reported. | Infants were monitored for apnea, bradycardia and aspiration pneumonia. | "There were no apenic, bradycardic events reported with oropharyngeal colostrum or sterile water administration." |
McFadden 2012 | No adverse effects have been reported | No pre‐defined adverse effects have been described in the study | Adverse effects were narratively reported as no adverse effects with the intervention. No numerical data were provided |
NCT02912585 | No adverse effects have been reported | No pre‐defined adverse effects have been described in the study | "The subjects tolerated the intervention and there were no adverse effects during the protocol treatment. No numerical data provided." |
Rodriguez 2011 | No adverse effects have been reported | No pre‐defined adverse effects have been described in the study | "All subjects tolerated the intervention and there were no recorded episodes of apnea, bradycardia, hypotension, desaturation or other adverse effects during the treatment protocol". No numerical data were provided |
Romano‐Keeler 2016 | No adverse effects have been reported | No pre‐defined adverse effects have been described in the study | "No adverse events were noted among patients in either group during the course of the study". No numerical data were provided |
Sohn 2015 | No adverse effects have been reported | No pre‐defined adverse effects have been described in the study | No data or comment in the report. |